G08743RW
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39112719 | Correction to: Anti-aging interventions in geriatric mice: insights into the timing of treatment, benefits, and limitations | Malavolta M | 2025 Mar 06 |
|
| 39514938 | Inhibition of coreopsin against α-amylase/α-glucosidase and synergy with acarbose | Cui J | 2025 Feb 01 |
|
| 39350934 | Integrative bioinformatic and experimental analysis of benzoylbenzodioxol derivatives: hypoglycemic potential in diabetic mice | Hawash M | 2024 Sep 28 |
|
| 39333445 | Repurposing metabolic regulators: antidiabetic drugs as anticancer agents | Dhas Y | 2024 Sep 28 |
|
| 39322747 | Acarbose enhances the efficacy of immunotherapy against solid tumours by modulating the gut microbiota | Zhang SL | 2024 Sep 25 |
|
| 39302570 | Therapeutic Potential of Luteolin for Diabetes Mellitus and Its Complications | Chang XQ | 2024 Sep 20 |
|
| 39287688 | Alternative agar substitutes for culturing unculturable microorganisms | Demin K | 2024 Sep 17 |
|
| 39271570 | Acarbose ameliorates Western diet-induced metabolic and cognitive impairments in the 3xTg mouse model of Alzheimer’s disease | Sonsalla MM | 2024 Sep 14 |
|
| 39264385 | Multifaceted therapeutic approach via thiazolidinedione-infused magnolol in chitosan nanoparticles targeting hyperlipidemia and oxidative stress in gestational diabetes mellitus in experimental mice | Li R | 2024 Sep 12 |
|
| 39259314 | Chnoospora minima: a Robust Candidate for Hyperglycemia Management, Unveiling Potent Inhibitory Compounds and Their Therapeutic Potential | Gunathilaka TL | 2024 Sep 11 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025